NUTMEG: A randomised phase II study of nivolumab and temozolomide (TMZ) versus TMZ alone in elderly patients with newly diagnosed glioblastoma (GBM): Trial in progress
Publication
, Conference
Khasraw, M; McDonald, KL; Yip, S; Verhaak, R; Heimberger, A; Hall, M; Fisher, L; Barnes, E; Rosenthal, M; Gedye, C; Hovey, E; Ellingson, BM ...
Published in: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
November 1, 2018
Duke Scholars
Published In
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
EISSN
1743-7563
ISSN
1743-7555
Publication Date
November 1, 2018
Volume
14
Start / End Page
196 / 197
Publisher
WILEY
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Khasraw, M., McDonald, K. L., Yip, S., Verhaak, R., Heimberger, A., Hall, M., … Lwin, Z. (2018). NUTMEG: A randomised phase II study of nivolumab and temozolomide (TMZ) versus TMZ alone in elderly patients with newly diagnosed glioblastoma (GBM): Trial in progress. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (Vol. 14, pp. 196–197). WILEY.
Khasraw, Mustafa, Kerrie L. McDonald, Sonia Yip, Roel Verhaak, Amy Heimberger, Merryn Hall, Lauren Fisher, et al. “NUTMEG: A randomised phase II study of nivolumab and temozolomide (TMZ) versus TMZ alone in elderly patients with newly diagnosed glioblastoma (GBM): Trial in progress.” In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 14:196–97. WILEY, 2018.
Khasraw M, McDonald KL, Yip S, Verhaak R, Heimberger A, Hall M, et al. NUTMEG: A randomised phase II study of nivolumab and temozolomide (TMZ) versus TMZ alone in elderly patients with newly diagnosed glioblastoma (GBM): Trial in progress. In: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY; 2018. p. 196–7.
Khasraw, Mustafa, et al. “NUTMEG: A randomised phase II study of nivolumab and temozolomide (TMZ) versus TMZ alone in elderly patients with newly diagnosed glioblastoma (GBM): Trial in progress.” ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol. 14, WILEY, 2018, pp. 196–97.
Khasraw M, McDonald KL, Yip S, Verhaak R, Heimberger A, Hall M, Fisher L, Barnes E, Rosenthal M, Gedye C, Hovey E, Ellingson BM, Simes J, Tongela A, Wheeler H, Koh E-S, Gan H, Back M, Lwin Z. NUTMEG: A randomised phase II study of nivolumab and temozolomide (TMZ) versus TMZ alone in elderly patients with newly diagnosed glioblastoma (GBM): Trial in progress. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY; 2018. p. 196–197.
Published In
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
EISSN
1743-7563
ISSN
1743-7555
Publication Date
November 1, 2018
Volume
14
Start / End Page
196 / 197
Publisher
WILEY
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis